Results 281 to 290 of about 2,938,349 (358)

Receptor Information System as the Infrastructure of Drug Design.

, 2000
K. Nakta
openalex   +2 more sources

Generate what you can make: achieving in-house synthesizability with readily available resources in de novo drug design. [PDF]

J Cheminform
Hassen AK, Šícho M, van Aalst YJ, Huizenga MCW, Reynolds DNR, Luukkonen S, Bernatavicius A, Clevert DA, Janssen APA, van Westen GJP, Preuss M.   +10 more
europepmc   +1 more source

Computer-aided drug design to generate a unique antibiotic family. [PDF]

Nat Commun
Barden CJ, Wu F, Fernandez-Murray JP, Lu E, Sun S, Taylor MM, Rushton AL, Williams J, Tavasoli M, Meek A, Reddy AS, Doyle LM, Sagamanova I, Sivamuthuraman K, Boudreau RTM, Byers DM, Weaver DF, McMaster CR.   +17 more
europepmc   +1 more source

Bis-3-chloropiperidines: a novel motif for anthelmintic drug design. [PDF]

RSC Adv
Kirchner M, Marner M, Kramer T, Mühlemeyer F, Eichberg J, Oberpaul M, Haeberlein S, Göttlich R.   +7 more
europepmc   +1 more source

Patient Safety, Potential Adverse Drug Events, and Medical Device Design: A Human Factors Engineering Approach

, 2001
Laura Lin, Kim J. Vicente, D. John Doyle
openalex   +1 more source

Editorial: Pharmacoinformatics: new developments and challenges in drug design. [PDF]

Front Pharmacol
Ramírez D, Peláez R, Lagos CF, Medina-Franco JL.   +3 more
europepmc   +1 more source

Computational drug design for neurosyphilis disease by targeting Phosphoglycerate Kinase in Treponema pallidum with enhanced binding affinity and reduced toxicity. [PDF]

Sci Rep
Naveed M, Ibrahim S, Aziz T, Asim M, Majeed MN, Khan AA, El Hadi Mohamed RA, Alwethaynani MS, Al-Joufi FA, Fallatah D.   +9 more
europepmc   +1 more source

Data-Directed Drug Design [PDF]

Nature Biotechnology, 1991
openaire   +3 more sources

DigFrag as a digital fragmentation method used for artificial intelligence-based drug design. [PDF]

Commun Chem
Yang R, Zhou H, Wang F, Yang G.
europepmc   +1 more source

2-Aminothiophene Derivatives-New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity. [PDF]

Pharmaceuticals (Basel)
de Araújo RSA, Bernardo VG, Tibúrcio RDS, Bedor DCG, Campos ML, Pontarolo R, de Sousa JMS, Rodrigues KADF, Scotti MT, Nayarisseri A, Marchand P, Mendonça-Junior FJB.   +11 more
europepmc   +1 more source